CD274 and neoplasm: Inoue et al20 demonstrated in a small cohort of patients similar trends using a different assay (FISH) to define PD-L1 amplification (defined as a PD-L1 to CEP9 ratio of at least 2.0; equivalent to CN ≥ 4 in diploid tumor samples).